Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Kidney Transplants Okay From Older Donors

By HospiMedica staff writers
Posted on 14 Feb 2006
Kidney transplants from donors older than 60 years of age can have a good outcome, providing the grafts are evaluated prior to implantation, according to a new study.

Researchers compared the outcomes of 62 patients given histologically evaluated kidneys from older donors with those of 248 matched recipients given non-evaluated kidneys from either older or younger donors. More...
All of the recipients were older than 50 years of age.
The kidneys were histologically evaluated and scored for a global rating of 0-12. Kidneys with a score of zero to three were used in single transplants, those scoring four to six were earmarked for dual transplants, and those rated seven or worse were discarded.

During a median follow-up period of 23 months, the rate of progression to dialysis was 6% in the group given evaluated grafts from older donors, 7% among recipients of kidneys from younger donors, and 23% among recipients of non-evaluated kidneys from older donors. Using an evaluated graft from an older donor, rather than a non-evaluated one, cut the risk of graft failure by 3.68-fold. The findings were published in the January 26, 2006, edition of The New England Journal of Medicine.

In both the overall and older donor group analysis, preimplantation histologic assessment of grafts was associated with significantly improved survival, noted Dr. Piero Ruggenenti, from the Mario Negri Institute for Pharmacological Research (Bergamo, Italy), and colleagues, who conducted the study.

The researchers concluded that the long-term survival of single or dual kidney grafts from donors older than 60 years of age is excellent, provided that the grafts are evaluated histologically before implantation. This approach could help to expand the donor-organ pool for kidney transplantation.



Related Links:
Pharmacological Research

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.